SCHEMBL4466769

SCHEMBL4466769

Oc1ccccc1C(S)c1nc(-c2ccncc2)c(-c2ccc(F)cc2)[nH]1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 4/20 0.61
MAPK14 Q16539 15/20 0.54
MAPK13 O15264 12/20 0.54
MAPK12 P53778 12/20 0.54
MAPK11 Q15759 12/20 0.54
GCGR P47871 11/20 0.54
CSNK1D P48730 4/20 0.53
CSNK1E P49674 3/20 0.53
PRKD3 O94806 2/20 0.53
MAP4K4 O95819 2/20 0.53
FRK P42685 2/20 0.53
MAPK9 P45984 2/20 0.53
CSNK1A1 P48729 2/20 0.53
GSK3B P49841 2/20 0.53
PTK6 Q13882 2/20 0.53
CLK4 Q9HAZ1 2/20 0.53
BRAF P15056 2/20 0.53
KDM4E B2RXH2 1/20 0.53
CIT O14578 1/20 0.53
GAK O14976 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4473119 0.81 MAPK14 (0.65) ALOX5MAPK14MAPK13MAPK12MAPK11
SCHEMBL6107665 0.80 MAPK14 (0.54) ALOX5MAPK14MAPK13MAPK12MAPK11
SCHEMBL1387734 0.79 MAPK14 (0.67) ALOX5MAPK14MAPK13MAPK12MAPK11
SCHEMBL9646788 0.79 MAPK14 (0.67) ALOX5MAPK14MAPK13MAPK12MAPK11
SCHEMBL4460361 0.76 MAPK14 (0.51) ALOX5MAPK14MAPK13MAPK12MAPK11
SCHEMBL8486608 0.76 MAPK14 (0.62) ALOX5MAPK14MAPK13MAPK12MAPK11
SCHEMBL4563107 0.76 ALOX5 (1.00) ALOX5MAPK14MAPK13MAPK12MAPK11
SCHEMBL8113784 0.75 MAPK14 (0.60) ALOX5MAPK14MAPK13MAPK12MAPK11
SCHEMBL6601709 0.75 MAPK14 (0.60) ALOX5MAPK14MAPK13MAPK12MAPK11
SCHEMBL5435972 0.74 KDM4E (0.48) ALOX5MAPK14MAPK13MAPK12MAPK11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7582660-B2 2-thio-substituted imidazole derivatives and their use in pharmaceutics C-A-I-R BIOSCIENCES GMBH (DE) 2009-09-01 US disclosed
US-20060235054-A1 2-Thio-substituted imidazole derivatives and their use in pharmaceutics MERCKLE-GMBH (DE) 2006-10-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060235054-A1 2-Thio-substituted imidazole derivatives and their use in pharmaceutics IL2, TPMT, IFNG ALOX5 1110/4885MAPK14 3841/4885MAPK13 3803/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.